The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma

导出原文传递

翻译打印收藏纠错

作者： Margherita Correnti ^[1] ; Andrea Cappon ^[2] ; Mirella Pastore ^[3] ; Benedetta Piombanti ^[4] ; Giulia Lori ^[5] ; Douglas V. P. N. Oliveira ^[6] ; Patricia Munoz‐Garrido ^[7] ; Monika Lewinska ^[8] ; Jesper B. Andersen ^[9] ; Cédric Coulouarn ^[10] ; Laurent Sulpice ^[11] ; Caterina Peraldo Neia ^[12] ; Giuliana Cavalloni ^[13] ; Santina Quarta ^[14] ; Alessandra Biasiolo ; Matteo Fassan ; Matteo Ramazzotti ; Matteo Parri ; Stefania Recalcati ; Luca Tommaso ; Claudia Campani ; Pietro Invernizzi ; Guido Torzilli ; Fabio Marra ; Patrizia Pontisso ; Chiara Raggi

作者单位： CHU Rennes,Inserm ^[1] Department of Biomedical Sciences for Health,University of Milan ^[2] Department of Experimental and Clinical Medicine,University of Florence ^[3] Department of Medicine‐DIMED,University of Padua ^[4] Biotech Research and Innovation Centre,University of Copenhagen ^[5] Division of Gastroenterology and Center for Autoimmune Liver Diseases,University of Milano‐Bicocca ^[6] CHU Rennes,INSERM 1241 ^[7] Department of Experimental and Clinical Biomedical Sciences,University of Florence ^[8] Center for Autoimmune Liver Diseases,Humanitas Clinical and Research Center ^[9] Department of Pathology,Humanitas Clinical and Research Center ^[10] Animal Care‐Polo Vallisneri University of Padua ^[11] Division of Medical Oncology,Candiolo Cancer Institute ^[12] Department of Hepatobiliary and General Surgery,Humanitas University ^[13] Cancer Genomics Lab,Fondazione Edo ed Elvo Tempia Valenta ^[14]

关键词 cancer stem cells cholangiocarcinoma invasion SerpinB3

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交